Grupo para la caracterización molecular de las neoplasias hematológicas
Pharmacoeconomics and Outcomes Research Iberia
Pozuelo de Alarcón, EspañaPublications en collaboration avec des chercheurs de Pharmacoeconomics and Outcomes Research Iberia (1)
2009
-
Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing crohn's disease
Journal of Clinical Gastroenterology, Vol. 43, Núm. 10, pp. 950-956